Agustin Melian

Insider Reports History

Entity
Individual
Location
C/O Allovir, Inc., 139 Main Street, Suite 500, Cambridge, MA
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Agustin Melian:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Chief Medical Officer Common Stock 454K $304K $0.67 Oct 4, 2021 Direct
Forma Therapeutics Holdings, Inc. EVP, Research & Development Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. EVP, Research & Development Stock Option (Right to Buy) 0 Oct 14, 2022 Direct

Insider Reports Filed by Agustin Melian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 2 $0 4 Oct 14, 2022 EVP, Research & Development
FMTX Forma Therapeutics Holdings, Inc. Jul 11, 2022 2 $0 4 Jul 12, 2022 EVP, Research & Development
FMTX Forma Therapeutics Holdings, Inc. Jul 11, 2022 0 $0 3 Jul 12, 2022 EVP, Research & Development
ALVR Allovir, Inc. Oct 4, 2021 4 -$447K 4 Oct 5, 2021 Chief Medical Officer
ALVR Allovir, Inc. Sep 28, 2021 1 -$90.4K 4 Sep 29, 2021 Chief Medical Officer
ALVR Allovir, Inc. Apr 5, 2021 4 -$897K 4 Sep 20, 2021 Chief Medical Officer